Brief: Amplia Therapeutics Says Grant Funding Received To Support Research Collaboration With Csiro
May 22 (Reuters) - Amplia Therapeutics Ltd ATX.AX :
* GRANT FUNDING RECEIVED TO SUPPORT RESEARCH COLLABORATION
WITH
CSIRO
* FUNDING TO DEVELOP NOVEL TOPICAL FORMULATIONS OF CO'S FAK
INHIBITORS
Source text for Eikon: ID:nASXbGpkT7
Further company coverage: ATX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Amplia Therapeutics
See all newsBrief: Amplia Therapeutics Signs Collaboration And Supply Agreement With Lilly
Australia's Amplia rises to 4-month high on Eli Lilly cancer drug trial collaboration
Brief: Amplia Therapeutics Says Warwick Tong Will Retire As Board Chairman
Brief: Amplia Therapeutics Reports Four Additional Complete Responses And Improved Overall Survival Data In Accent Pancreatic Cancer Trial
Brief: Amplia Therapeutics Requests Trading Halt Pending Clinical Trial Results Announcement